Delivery Order SPE2DB24D1007-SPE2DB25FCBLF
Award Date 4/24/25
Potential Completion Date 4/25/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,138.04 to AmerisourceBergen Drug Corp for the supply of Amlodipine-Valsartan 10-160 mg tablets (30-count) on June 20, 2025, with an ultimate completion date of June 23, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,703.95 to AmerisourceBergen Drug Corp for the supply of Amlodipine-Valsartan 10-320 mg tablets (30-count units) on August 22, 2025, with completion targeted for August 25, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $1,700.58 to AmerisourceBergen Drug Corp for Amlodipine-Valsartan 5-160 mg tablets (30-count) on September 8, 2025, with a completion date of September 9, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance. The award represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Amlodipine-Valsartan 5-160 mg tablets (30-count units) valued at $23,768.80. This competitively awarded, non-set-aside delivery order employs firm fixed pricing and is scheduled for completion by September 17, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $11,424.98 to AmerisourceBergen Drug Corp for the supply of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 mg tablets in a 30-count quantity. This competitive, non-set-aside award was executed on August 7, 2025, with an ultimate completion date of August 8, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The firm fixed price delivery order structure reflects the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,437.87, is for the delivery of Amlodipine-Valsartan 10-320 mg tablets. This is a firm fixed-price delivery order contract with a completion date of February 13, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite...
- The Defense Logistics Agency awarded a $3,819.87 delivery order to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-12.5 mg tablets (90-count) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Amlodipine-Valsartan 5-160 mg 30s medication. The $12,960.31 contract has a performance period through March 7, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp is also the prime contractor on a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA, which serves as the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,362.54 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 320-25 mg tablets (90-count) on August 18, 2025, with completion expected by August 19, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under an open contracting vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $1,337.76 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-320-25 MG in a 30-count package. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, due for completion by September 8, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...